CRON FY 2023 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$87M+0.6% YoY

Gross Profit

$12M13.7% margin

Operating Income

-$85M-97.2% margin

Net Income

-$74M-84.8% margin

EPS (Diluted)

$-0.19

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$46M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$44M

Stockholders' Equity

$1.1B

Cash & Equivalents

$669M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$87M	$87M	+0.6%
Gross Profit	$12M	$15M	-22.8%
Operating Income	-$85M	-$111M	+23.9%
Net Income	-$74M	-$169M	+56.2%